Annual trends in glycemic control and prescribing patterns in diabetic treatment according to age in Japanese patients with type 2 diabetes between 2012 and 2019 (JDDM 71)-Reference-Cited by-同舟云学术

Annual trends in glycemic control and prescribing patterns in diabetic treatment according to age in Japanese patients with type 2 diabetes between 2012 and 2019 (JDDM 71)

Published:2023-04 Issue: Volume:198 Page:110599
ISSN:0168-8227
Container-title:Diabetes Research and Clinical Practice
language:en
Short-container-title:Diabetes Research and Clinical Practice

Author:

Miyazawa Itsuko,Yokoyama Hiroki,Yagi Noriharu,Araki Shin-ichi,Morino Katsutaro,Kume Shinji,Shirabe Shinichirou,Yamazaki Katsuya,Maegawa Hiroshi

Publisher

Elsevier BV

Subject

Endocrinology,General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference36 articles.

1. Statistics Bureau of Japan. Population of the elderly 2021. https://www.stat.go.jp/data/topics/topi1291.html (accessed 11/30 2021).

2. Japan Diabetes Society /Japan Geriatrics Society Joint Committee on Improving Care for Elderly Patients with D, Haneda M, Ito H. Glycemic targets for elderly patients with diabetes. Diabetol Int 2016; 7(4): 331-3.

3. Japanese Clinical Practice Guideline for Diabetes 2019;Araki;Diabetol Int,2020

4. Japan Diabetes Clinical Data Management Study Group. Basic study of JDDM. 2022. http://jddm.jp/public-information/index-2020/#data_03 (accessed 4/12 2022).

5. Changes in oral antidiabetic prescriptions and improved glycemic control during the years 2002–2011 in Japan (JDDM32);Oishi;J Diabetes Investig,2014

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PIONEER REAL Japan: Primary results from a multicenter, prospective, real‐world study of oral semaglutide in adults with type 2 diabetes in Japanese clinical practice;Journal of Diabetes Investigation;2024-08-22

2. Efficacy and safety of oral semaglutide in older patients with type 2 diabetes: a retrospective observational study (the OTARU-SEMA study);BMC Endocrine Disorders;2024-07-24

3. PIONEER REAL Japan: Baseline characteristics of a multicenter, prospective, real‐world study of oral semaglutide in adults with type 2 diabetes in clinical practice in Japan;Journal of Diabetes Investigation;2024-05-06

4. Efficacy and safety of oral semaglutide in older patients with type 2 diabetes: a retrospective observational study (the OTARU-SEMA study);2024-02-07

5. Glycaemic control efficacy of switching from dipeptidyl peptidase‐4 inhibitors to oral semaglutide in subjects with type 2 diabetes: A multicentre, prospective, randomized, open‐label, parallel‐group comparison study (SWITCH‐SEMA 2 study);Diabetes, Obesity and Metabolism;2023-12-11